Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07456865) titled 'Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device' on March 2.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: MedtronicNeuro

Condition: Urge Urinary Incontinence

Intervention: Device: Altaviva™ system

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: February 2026

Target Sample Size: 256

To know more, visit https://clinicaltrials.gov/study/NCT07456865

Published by HT Digital Content Services with permissio...